Logo
Global Fibrinogen Market, 2020-2026

Global Fibrinogen Market, 2020-2026

Bonafide Trust 26-03-2020 96 Pages
Region : Global Category : Lifescience Pharmaceutical

Fibrinogen (factor I) is a soluble plasma glycoprotein with a molecular weight of about 340 kDa. The native molecule is a dimer and consists of three pairs of polypeptide chains (A?, B? and ?). Fibrinogen finds application in the treatment of fibrinogen deficiencies and control of bleeding during surgeries. According to Gen Consulting Company, global fibrinogen market is expected to reach USD 1,935.8 million by the end of 2026, expanding at a CAGR of 6.11% over the forecast period i.e. 2020 2026. Growing potential for fibrinogen in haemostatic therapy sector is the chief contributor for the growth of the market. The fibrinogen market is segmented on the basis of application, and region. By application, the fibrinogen market is classified into Haemostatic Therapy, Research Use. On the basis of region, the fibrinogen industry is analyzed across North America, Europe, Asia Pacific, South America and MEA (the Middle East, and Africa). By Application: Haemostatic Therapy Research Use By region, the market is analyzed across North America, Asia Pacific, Europe, Middle East & Africa and South America. This report forecasts revenue growth at global, regional & country level from 2020 to 2026. North America (U.S., Canada, Mexico, etc.) Asia Pacific (China, Japan, India, Korea, Australia, Indonesia, Taiwan, Thailand, etc.) Europe (Germany, UK, France, Italy, Russia, Spain, etc.) Middle East & Africa (Turkey, Saudi Arabia, Iran, Egypt, Nigeria, UAE, Israel, South Africa, etc.) South America (Brazil, Argentina, Colombia, Chile, Venezuela, Peru, etc.) The market research report covers the analysis of key stake holders of the fibrinogen market. Some of the leading players profiled in the report include: Baxter International Inc. CSL Behring LLC Green Cross Corporation Harbin Pacific Biopharmaceutical Co., Ltd. Hualan Biological Engineering Inc. Jiangxi Boya Bio Pharmaceutical Co., Ltd. Johnson & Johnson (Ethicon, Inc.) LFB S.A. ProFibrix BV (The Medicines Company) Shanghai RAAS Blood Products Co., Ltd. Shanghai Xinxing Medicine Co., Ltd. *list is not exhaustive, request free sample to get a complete list of companies The base year of the study is 2019, and forecasts run up to 2026. Research Objective To analyze and forecast the market size of global fibrinogen market. To classify and forecast global fibrinogen market based on application, and region. To identify drivers and challenges for global fibrinogen market. To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in global fibrinogen market. To conduct pricing analysis for global fibrinogen market. To identify and analyze the profile of leading players operating in global fibrinogen market. The report is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities. Key target audience are: Manufacturers of fibrinogen Raw material suppliers Market research and consulting firms Government bodies such as regulating authorities and policy makers Organizations, forums and alliances related to fibrinogen

Read More

Card image cap

Interested in this report?
Get your FREE sample!

Requirement Gathering & Methodology
Data Collection Techniques
Our Research Team & Data Sourcing
Data Science & Analytical Tools
Data Visualization & Presentation Skills
Project/ Report Delivery & After Sales Services